CIK 0000899923
- Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 870494517
- Phone
- +1 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale President Myriad RBM, Inc. sold 1,975 shares at $31.00 ($61,225)
- 4 Returned to the company President Crescendo BioScience returned 3,734 shares (to the company)
- 4 Grant or award Director acquired 9,360 shares (grant or award)
- 4 Grant or award Director acquired 9,360 shares (grant or award)
- 4 Grant or award Director acquired 9,360 shares (grant or award)
- 4 Grant or award Director acquired 9,360 shares (grant or award)
- 4 Grant or award Director acquired 9,360 shares (grant or award)
- 4 Grant or award Director acquired 9,360 shares (grant or award)
- 4 Returned to the company Chief Financial Officer returned 3,327 shares (to the company)
- 4 Returned to the company President Myriad RBM, Inc. returned 5,313 shares (to the company)
- 4 Returned to the company President Assurex Health Inc. returned 725 shares (to the company)
- 4 Returned to the company Exec. VP International Ops returned 7,153 shares (to the company)
- 4 Returned to the company President Myriad Oncology returned 1,258 shares (to the company)
- 4 Returned to the company President Crescendo BioScience returned 11,107 shares (to the company)
- 4 Returned to the company President, MGL returned 8,483 shares (to the company)
- 4 Returned to the company Chief Scientific Officer returned 10,701 shares (to the company)
- 4 Returned to the company E.V.P., General Counsel returned 10,542 shares (to the company)
- 4 Returned to the company Chief Financial Officer returned 11,942 shares (to the company)
- 4 Returned to the company President & C.E.O. returned 27,022 shares (to the company)
Page 25 of 65 · 1,294 filings